# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-15-002677
Filing Date
2015-04-07
Accepted
2015-04-07 17:00:41
Documents
3
Period of Report
2015-05-22
Effectiveness Date
2015-04-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | t1500784_def14a.htm | DEF 14A | 608328
2 | GRAPHIC | t1500784_pc1.jpg | GRAPHIC | 556695
3 | GRAPHIC | t1500784_pc2.jpg | GRAPHIC | 436543
| Complete submission text file | 0001571049-15-002677.txt |  | 1978253

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 15757292
SIC: 2834 Pharmaceutical Preparations